Camlin Fine Sciences Limited · NSE:CAMLINFINE
Camlin Fine Sciences — Q4 FY22 Earnings Presentation
41 slides from Camlin Fine Sciences's earnings presentation, May 20, 2022
Slide 1: Regulation 30 intimation letter to stock exchanges
May 20, 2022 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai‐ 400051 Ref: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation purs
Slide 2: Camlin Fine Sciences Ltd. Investor Presentation – May 2022
Camlin Fine Sciences Ltd. Investor Presentation – May 2022
Slide 3: Safe Harbour
Safe Harbour 5 This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for a
Slide 4: Q4 & FY22 Highlights
Q4 & FY22 Highlights #start your story
Slide 5: Q4 FY22 Operational Highlights
Q4 FY22 Operational Highlights 5 Q4 Rs 3,892 mn Rs 243 mn Rs 133 mn FY22 Revenue EBITDA PAT 19% growth on YoY basis -52% growth on YoY basis -15% growth on YoY basis › Growth momentum continues across all geographies and verticals, revenues grow by 19% year on year › Despite increase in feedstocks a
Slide 6: Performance Highlights
Performance Highlights 5 Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 15.4% 14.5% 6.3% 4.8% 7.1% 3.4% Margin +19% Quarterly Highlights -52% -15% 3,808.2 3,892.3 3,266.0 551.7 271.5 504.0 157.0 243.3 133.3 Q4FY21 Q3FY22 Q4FY22 Q4FY21 Q3FY22 Q4FY22 Q4FY21 Q3FY22 Q4FY22 15.3% 10.8% 5.5% 4.3%
Slide 7: Operational Revenue Break-up
Operational Revenue Break-up 5 Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) +33% +26% +29% 3,812 4,168 7,980 2,860 3,311 6,171 +40% +28% +34% 1,056 1,086 2,141 753 850 1,602 Q4FY21 Q4FY22 FY21 FY22 Q4FY21 Q4FY22 FY21 FY22 Q4FY21 Q4FY22 FY21 FY22 Performan
Slide 8: Regional Highlights
Regional Highlights 5 CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) +14% +17% +17% 6,855 3,198 4,395 6,000 2,735 3,762 +20% +35% +11% 2,014 1,343 1,685 695 772 996 Q4FY21 Q4FY22 FY21 FY22 Q4FY21 Q4FY22 FY21 FY22 Q4FY21 Q4FY22 FY21 FY22 CFS Brazil (Rs. In Mn) CFS Wanglong (Rs. I
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement 5 Particulars (Rs. In Mn) Q4 FY22 Q4 FY21 YoY FY22 FY21 YoY Revenue from Operation 3,892.3 3,266.2 19.2% 14,120.9 11,871.0 19.0% Raw material consumption 2,027.7 1,659.5 7,594.9 5,834.9 Employee Cost 377.5 351.1 1,450.5 1,203.8 Other expenses 1,243.8 751.3 3,547.
Slide 10: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement 5 Particulars (Rs. In Mn) Q4 FY22 Q4 FY21 YoY FY22 FY21 YoY Revenue from Operation 2,013.9 1,684.6 19.5% 6,855.1 4,315.9 58.8% Raw material consumption 1,045.8 1,054.4 3,945.0 2,729.6 Employee Cost 132.0 115.2 528.9 271.8 Other expenses 523.2 319.1 1,606.4 902.2 EB
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet 5 Particulars (Rs. In Mn) Mar - 22 Mar - 21 Particulars (Rs. In Mn) Mar - 22 Mar - 21 Equity Non-Current assets Equity Share Capital 157.0 127.5 Property, Plant and Equipment 4,818.3 4,817.5 Capital Work-In-Progress 2,147.1 236.8 Other Equity 7,322.4 6,306.5 Right use of a
Slide 12: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement 5 Particulars (Rs. In mn) Mar - 22 Mar - 21 Net Profit Before Tax 939.8 1,051.0 Adjustments for: Non Cash Items / Other Investment or Financial Items 754.9 1,141.5 Operating profit before working capital changes 1,694.7 2,192.5 Changes in working capital 63.5 -659.3
Slide 13: Bringing Science to Everyday Life
B r i n g i n g S c i e n c e t o E ve r y d ay L i fe #start your story
Slide 14: Company Overview
Company Overview 5 Camlin Fine Sciences Ltd. is a vertically integrated company, engaged in the research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. 2006 Leading Preferred manufacturer of Partner for Established Antioxidants Customised Products Rs 1
Slide 15: Business Verticals & Industries Served
Business Verticals & Industries Served 5 Business Mix FY22* 1% <2% 42% 57% Sales Mix End User Industries › Feed & Food › Functional Foods › Pharma Intermediates › Food › Personal Care & Home Care › Livestock Feed › Petrochemicals › Animal Nutrition › Flavours & Fragrances › Dietary Supplements › Dye
Slide 16: Strategically Located
Strategically Located 5 80+ Countries USA Italy China Presence Mexico Cuba India Dominican Gautemala Republic Colombia Singapore 1,000+ Customers Peru Brazil Chille Argentina CFS Wanglong CFS North CFS Dresen (Dresen Camlin Fine Sciences & ` CFS do Brasil Ltda. CFS Europe SpA Flavours (Ningbo), Amer
Slide 17: Global Research & Development
Global Research & Development 5 Application Labs › Develops customized blends for various applications › Provides technical assistance and development support to customers • Mexico City › Tests of defined performance parameters • Des Moines, USA › Conducts stability studies for various products of s
Slide 18: Over The Decades, A Prestigious Brand Has Emerged
Over The Decades,A Prestigious Brand Has Emerged 5 FY94 FY07 FY12 FY14 › Camlin Fine Chemical division › Camlin Fine Sciences Ltd. was › Acquired Borregaard Italia › Introduced extensive range of incorporated in Camlin Ltd. to formed after de-merging SpA, a manufacturing facility in performance chem
Slide 19: Complex Chemistry With High Barriers
Complex Chemistry With High Barriers 5 Long Gestation Period High Replacement Cost Tight Regulations Our global presence, growing scale, Complying with a wide range of laws, Customer acquisition takes a long reliable supply chain, rationalized cost regulations and practices, including time, thus the
Slide 20: Key Strengths
Key Strengths 5 1 Leading, global player in shelf-life solutions across food, feed, pet-food and Biodiesel 2 Local presence in major global markets 3 Advanced R&D facilities & Application Labs 4 Proven ability to acquire and improve business performance 5 Vertically integrated across the value chain
Slide 21: Business Overview
Business Overview #start your story
Slide 22: Shelf Life Solutions
Shelf Life Solutions 5 End User Industries Total Operational Revenue (Rs. in Mn) Product portfolio 7,980 Foods 6,171 Antioxidants (straights) Blends & Other Additives 5,516 3,812 4,856 2,860 Established player in the global market with over 3,606 2,381 Pet Food 2,248 30 years of experience 1,571 4,1
Slide 23: Performance Chemicals
Performance Chemicals 5 End User Industries › Performance Chemicals are specialty chemicals sold on the basis of their Total Operational Revenue (Rs. in Mn) performance for specific industrial applications › Entered into a long-term preferred supply agreement with Lockheed Martin Advanced Energy Sto
Slide 24: Aroma Ingredients
Aroma Ingredients 5 End User Industries › CFS produces Vanillin through the Catechol route and its brand is one of the Total Operational Revenue (Rs. in Mn) most trusted by the Food and Flavours Industry. › Vanillin is a synthetic substitute to natural vanilla derived from vanilla beans, which is ve
Slide 25: Health & Wellness
Health & Wellness 5 End User Industries › Launched in 2019 to cater to the rising awareness and growing demand for natural products. › Offers nutraceutical products derived by plant extraction and fermentation such as natural colours, Pet Food functional ingredients, plant-based extracts in natural
Slide 26: CFS 2.0
CFS 2.0 #start your story
Slide 27: CFS 2.0
CFS 2.0 5 CFS CFS 1.0 2.0 Further Improving Advancing Expansion in Preparing Operational Growth Acceleration Downstream For Future Efficiencies Strategies Products 26
Slide 28: Manufactured In-house: Integration Chain
Integration Chain 5 Phenol Manufactured In-house Hydroquinone Diphenols Catechol Performance Performance Shelf Life Solutions Chemicals Aroma Ingredients Chemicals Ascorbyl Palmitate1 TBHQ MEHQ Guaiacol Guethol BHA Other derivatives of HQ Veratrole Vanillin Other derivatives of Blends Catechol Ethyl
Slide 29: Improving Operational Efficiencies
Improving Operational Efficiencies 5 Key Rational Before Dahej Expansion: After Dahej Expansion: › Backward Integrated through Italy & Dahej Facility › Diphenols were manufactured in Italy and › Diphenol captive requirement in India will be met › Became one of the leading low cost transported to man
Slide 30: Well Placed to Expand Downstream Products
Well Placed to Expand Downstream Products 5 Wide Product Basket Key Products Our Presence Hydroquinone Catechol › High Volatile Business › High Volatile Business › Supply Deficit in Global Market › Oversupply in Global Market MEHQ ✓ › High Demand › Moderate Demand BHA ✓ Guaiacol ✓ Ascorbyl Palmitate
Slide 31: Advancing Our Growth Strategy
Advancing Our Growth Strategy 5 › With a diverse product portfolio, worldwide presence, › 15,000 MT greenfield facility at Dahej, Gujarat strengthens the CFS continuous focus on R&D, and healthy financial position, CFS is capabilities in Diphenols well-positioned to benefit from sectoral tailwinds.
Slide 32: Preparing For Future Growth
Preparing For Future Growth 5 Building Additional Multipurpose Plant › Setting up 6,000 MT Vanillin facility at Dahej, Gujarat to make Guaiacol (raw material for Vanillin), Vanillin, Ethyl Vanillin, Methyl Vanillin, and its derivatives › The low-cost Catechol obtained from & the latest Dahej facilit
Slide 33: Way Forward : Acceleration
Way Forward : Acceleration 5 Acceleration SHELF-LIFE SOLUTIONS AROMA INGREDIENTS › Increasing focus on high margin blends and › Setting up 6,000 MT Vanillin facility at Dahej additives › Focusing on cost efficient manufacturing of › Introducing new products, cross-selling Vanillin leading to improve
Slide 34: ESG Highlights
ESG Highlights 5 › Carefully chosen product portfolio to provide environmental benefits addressing large societal challenges like food waste prevention. Environment › CFS is proactively working towards sourcing clean energy from wind energy farm with a capacity of 1.25MW which could replace upto 20%
Slide 35: Key Clients and Certificates
Key Clients and Certificates 5 Key Clients Key Certificates The Brand Names and Logos mentioned are the property of their respective owners and are used here for identification purposes only 34
Slide 36: Board of Directors
Board of Directors 5 Ashish Dandekar Nirmal Momaya Arjun Dukane Harsha Raghavan Chairman & Managing Director Managing Director Executive Director - Technical Non Executive Non-Independent • BA in Economics and Management studies form • CA with over 25 years of experience in Finance, Taxation, • Chem
Slide 37: Financial Highlights
Financial Highlights #start your story
Slide 38: Operational Revenue Break-Up
Operational Revenue Break-Up 5 Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) 3,812 4,168 7,980 2,860 3,135 3,311 6,171 5,516 2,248 2,381 2,608 4,856 2,035 3,606 1,571 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 Performance Ch
Slide 39: Regional Highlights
Regional Highlights 5 CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 6,855 3,198 4,395 5,798 6,000 2,735 3,762 5,481 2,571 3,296 3,091 2,172 2,771 4,050 1,642 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 CFS Brazil (Rs. In Mn) CFS Wanglong (Rs. In M
Slide 40: Historical Financial Highlights
Historical Financial Highlights 5 Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 1.7% 7.7% 12.5% 15.3% 10.8% -3.3% 0.3% 2.8% 5.5% 4.3% Margin 14,121 +18% +87% 1,819 654 604 11,871 10,491 1,528 8,922 1,307 7,228 298 687 30 126 FY18 FY19 FY20 FY21 FY22 FY18 FY19 FY20 FY21 FY22 -240 FY18 FY19 F
Slide 41: Thank You
Thank You Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Mr. Santosh Parab- CFO Email – santosh.parab@camlinfs.com www.camlinfs.com #start your story Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Jigar Kavaiya Email – jigar.kavaiya@sgapl.net www.sgapl.net 40